Jubilant Pharmova Limited - Asset Resilience Ratio

Latest as of March 2025: 1.26%

Jubilant Pharmova Limited (JUBLPHARMA) has an Asset Resilience Ratio of 1.26% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Jubilant Pharmova Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Rs1.61 Billion

≈ $17.41 Million USD Cash + Short-term Investments

Total Assets

Rs127.56 Billion

≈ $1.38 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Jubilant Pharmova Limited's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Jubilant Pharmova Limited total assets.

Liquid Assets Composition Over Time

This chart breaks down Jubilant Pharmova Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Jubilant Pharmova Limited balance sheet liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Rs0.00	0%
Short-term Investments	Rs1.61 Billion	1.26%
Total Liquid Assets	Rs1.61 Billion	1.26%

Asset Resilience Insights

Limited Liquidity: Jubilant Pharmova Limited maintains only 1.26% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jubilant Pharmova Limited Industry Peers by Asset Resilience Ratio

Compare Jubilant Pharmova Limited's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Jiangsu Hengrui Medicine Co Ltd SHG:600276	Drug Manufacturers - Specialty & Generic	0.16%
Viatris Inc NASDAQ:VTRS	Drug Manufacturers - Specialty & Generic	1.48%
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	Drug Manufacturers - Specialty & Generic	48.48%
Neuland Laboratories Limited NSE:NEULANDLAB	Drug Manufacturers - Specialty & Generic	9.65%
Shanghai Haoyuan Chemexpress Co. Ltd. A SHG:688131	Drug Manufacturers - Specialty & Generic	1.37%
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	Drug Manufacturers - Specialty & Generic	-2.56%

Annual Asset Resilience Ratio for Jubilant Pharmova Limited (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Jubilant Pharmova Limited.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-03-31	0.00%	Rs5.00 Million ≈ $54.07K	Rs127.56 Billion ≈ $1.38 Billion	+0.00pp
2024-03-31	0.00%	Rs4.00 Million ≈ $43.26K	Rs115.48 Billion ≈ $1.25 Billion	+0.00pp
2023-03-31	0.00%	Rs3.84 Million ≈ $41.53K	Rs111.57 Billion ≈ $1.21 Billion	-0.05pp
2022-03-31	0.05%	Rs53.53 Million ≈ $578.91K	Rs99.91 Billion ≈ $1.08 Billion	-2.05pp
2021-03-31	2.10%	Rs1.87 Billion ≈ $20.27 Million	Rs89.18 Billion ≈ $964.46 Million	+0.61pp
2020-03-31	1.50%	Rs1.87 Billion ≈ $20.27 Million	Rs125.22 Billion ≈ $1.35 Billion	-1.79pp
2019-03-31	3.29%	Rs3.77 Billion ≈ $40.77 Million	Rs114.69 Billion ≈ $1.24 Billion	+2.98pp
2018-03-31	0.31%	Rs294.56 Million ≈ $3.19 Million	Rs96.18 Billion ≈ $1.04 Billion	+0.15pp
2017-03-31	0.16%	Rs144.88 Million ≈ $1.57 Million	Rs90.41 Billion ≈ $977.71 Million	+0.10pp
2016-03-31	0.06%	Rs53.16 Million ≈ $574.91K	Rs89.47 Billion ≈ $967.59 Million	-0.02pp
2015-03-31	0.08%	Rs66.49 Million ≈ $719.06K	Rs86.32 Billion ≈ $933.54 Million	+0.01pp
2014-03-31	0.07%	Rs57.63 Million ≈ $623.25K	Rs88.61 Billion ≈ $958.24 Million	+0.02pp
2013-03-31	0.05%	Rs40.53 Million ≈ $438.32K	Rs84.32 Billion ≈ $911.89 Million	--

pp = percentage points

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.58 Billion

Rs146.43 Billion INR

Market Cap Rank

#7061 Global

#347 in India

Share Price

Rs924.50

Change (1 day)

+1.83%

52-Week Range

Rs807.65 - Rs1181.20

All Time High

Rs1269.00